Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Faron Pharmaceuticals (FARN) Share News

234567891011

Faron Pharmaceuticals To Raise EUR2.1 Million For Clevegen Development

5th Aug 2019 12:26

(Alliance News) - Faron Pharmaceuticals Oy on Monday announced a EUR1.1 million subscription and EUR2.0 million open offer to fund the clinical development of cancer drug Clevegen.Shares in Read More

WINNERS & LOSERS SUMMARY: Thomas Cook Plunges On Rescue Deal Talks

12th Jul 2019 10:35

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------BHP up 1.5%. The - Read More

Faron Pharma Pleased By MATINS Progress And Plans To Increase Capacity

12th Jul 2019 10:20

(Alliance News) - Faron Pharmaceuticals Oy said on Friday its MATINS study of nine cancer patients is progressing well, and it is planning to expand the clinical trial to more countries.The Read More

Faron Pharmaceuticals Says Traumakine Study Hindered By Steroid Use

26th Jun 2019 11:52

(Alliance News) - Faron Pharmaceuticals Oy on Wednesday said interim results from its phase two Inforaaa study support continuation but the study is limited by a lack of patients not also taking a Read More

Faron Pharmaceuticals' Analysis Explains "Disappointing" Prior Trial

14th Jun 2019 11:54

(Alliance News) - Faron Pharmaceuticals Oy on Friday said analysis of a more recent trial of Traumakine has explained why the drug did not perform as expected in a previous trial.Shares in Read More

Faron Pharma Finance Head Wichmann Steps Down, Hanninen Replaces

24th May 2019 13:34

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Friday said it has made several managerial changes, which it believes will strengthen its operating performance.The clinical stage said Read More

Faron Pharmaceuticals Raises EUR1.3 Million Via Share Subscription (ALLISS)

14th May 2019 14:16

LONDON (Alliance News) - Biopharmaceutical company Faron Pharmaceuticals Ltd said Tuesday that it has raised EUR1.3 million via share subscription.The company has issued 1.8 million shares Read More

Faron Pharmaceuticals Narrows Loss On Reduced Clinical Trial Costs

7th May 2019 11:44

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Tuesday reported a slightly narrowed annual loss as the drug developer's research & development costs fell.Faron is a clinical Read More

Faron Pharmaceuticals Knows Of No Reason For 43% Share Price Jump

2nd May 2019 17:30

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Thursday said it is unable to explain the recent movement in its share price.Faron noted Thursday's 43% share price rise, and said Read More

UK Earnings, Trading Statements Calendar - Next 7 Days

30th Apr 2019 16:02

Wednesday 1 May J SainsburyFull Year ResultsConnect GroupHalf Year GroupQ1 Stock Read More

Faron Gets Results Of Traumakine Study From Japanese Licensing Partner

29th Apr 2019 15:46

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said its Japanese licensing partner Maruishi Pharmaceutical Co Ltd has provided clinical trial results on its phase three Traumakine for Read More

Faron Pharmaceuticals To Focus On Colorectal Cancer In Clevegen Trial

11th Apr 2019 12:13

LONDON (Alliance News) - Faron Pharmaceuticals Oy is to target colorectal cancer in its upcoming test programme for Clevegen, it said Thursday.The testing of Clevegen on patients with will Read More

UPDATE: Faron Pharmaceuticals Raises EUR3.1 Million In Fundraise (ALLISS)

26th Mar 2019 15:52

LONDON (Alliance News) - Finland's Faron Pharmaceuticals Oy on Tuesday afternoon said it has raised EUR3.1 million pursuant to a placing announced earlier in the day.The company issued Read More

Faron Pharmaceuticals Optimistic For Traumakine As It Plans Fundraise (ALLISS)

26th Mar 2019 12:05

LONDON (Alliance News) - Finland's Faron Pharmaceuticals Oy on Tuesday said it expects further disappointing results from Traumakine, as it plans a share placing.Faron is currently for Read More

Faron "Very Encouraged" By Early Clevegen Trials In Cancer Patients

21st Feb 2019 12:17

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Thursday said early results from a trial of its Clevegen cancer drug are encouraging.Shares in Faron were up 10% at 64.00 pence on said Read More

Faron Pharmaceuticals Encouraged By Clever-1 Antibody Study Result

13th Feb 2019 12:20

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Wednesday said new data supports the use of Clever-1 antibodies in re-activating an immune response to tumours.Shares in Faron were up Read More

WINNERS & LOSERS SUMMARY: Ashtead Falls On US Economic Slowdown Worry

5th Dec 2018 11:19

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 2.7%. Japan's Takeda Pharmaceutical Read More

Faron Pharmaceuticals Finds "Optimal" Patient Group For Traumakine

5th Dec 2018 09:09

LONDON (Alliance News) - Faron Pharmaceuticals Ltd shares jumped on Wednesday as the company said it identified an "optimal" subgroup of patients, with a certain genetic mutation, to be Read More

WINNERS & LOSERS SUMMARY: McColl's Retail Plunges After Profit Warning

3rd Dec 2018 10:50

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 8.9%, Evraz, up 7.8%, up Read More

DIRECTOR DEALINGS: Faron Divisional Chief Medical Officer Buys Shares

6th Nov 2018 16:29

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Tuesday said VP Drug Development Chief Medical Officer Matti Karvonen acquired shares in the biopharmaceutical company.In a transaction Read More

234567891011
FTSE 100 Latest
Value10,600.53
Change-2.95